Form D Explorer

Source evidence

TenNor Therapeutics (Suzhou) Ltd · 0001104659-26-066134

D filed May 26, 2026. Extracted source facts are preserved separately from the current issuer profile and normalized display values.

SEC filing indexDownload stored sourceReport a record issue

Explicit source references

These accession references come from the source document. They describe a reported link; they do not establish new financing or an independently verified offering group.

Identity as reported in this document

city
SUZHOU
street1
UNIT 701, BLOCK B7, BIOBAY
street2
218 XINGHU STREET
zipCode
215123
entityName
TenNor Therapeutics (Suzhou) Ltd
entityType
Corporation
stateOrCountry
F4
jurisdictionOfInc
CHINA
Individual source fields, including raw text and value state
FieldRaw sourceStateParsed valueSource location
Reported finders fees0number0/edgarSubmission/offeringData/salesCommissionsFindersFees/findersFees/dollarAmount
Reported amount sold14699667number14699667/edgarSubmission/offeringData/offeringSalesAmounts/totalAmountSold
Reported sales commissions0number0/edgarSubmission/offeringData/salesCommissionsFindersFees/salesCommissions/dollarAmount
Reported offering amount14699667number14699667/edgarSubmission/offeringData/offeringSalesAmounts/totalOfferingAmount
Reported minimum investment0number0/edgarSubmission/offeringData/minimumInvestmentAccepted
Reported investor count1number1/edgarSubmission/offeringData/investors/totalNumberAlreadyInvested

Document SHA-256: b94c06b9887efe22c0cc5be7f88f0bf9f561d8322d6a2dca68ce279cc338d7df. This proves extraction identity, not the accuracy of the filer's claims.